Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
101
102
103
104
105
…
Go to page
Go
126
Next
First
Prev
103 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
About CDER Small Business and Industry Assistance (SBIA)
FDA
Feb 1, 2022
Replies
0
Views
260
Feb 1, 2022
FDA
F
E
A stronger role for EMA , , 31/01/2022
EMA
Feb 1, 2022
Replies
0
Views
293
Feb 1, 2022
EMA
E
F
FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer
FDA
Feb 1, 2022
Replies
0
Views
309
Feb 1, 2022
FDA
F
F
FDA approves pembrolizumab combination for the first-line treatment of cervical cancer
FDA
Feb 1, 2022
Replies
0
Views
269
Feb 1, 2022
FDA
F
F
Advances in FDA's Drug Safety Programs
FDA
Feb 1, 2022
Replies
0
Views
239
Feb 1, 2022
FDA
F
F
FDA approves abemaciclib with endocrine therapy for early breast cancer
FDA
Feb 1, 2022
Replies
0
Views
220
Feb 1, 2022
FDA
F
F
FDA approves brexucabtagene autoleucel for relapsed or refractory B-cell precursor acute lymphoblastic leukemia
FDA
Feb 1, 2022
Replies
0
Views
254
Feb 1, 2022
FDA
F
F
FDA-ASCO Hematology and Oncology Fellows Day Workshop. - 11/16/2021
FDA
Feb 1, 2022
Replies
0
Views
240
Feb 1, 2022
FDA
F
F
FDA approves ruxolitinib for chronic graft-versus-host disease
FDA
Feb 1, 2022
Replies
0
Views
239
Feb 1, 2022
FDA
F
F
FDA grants accelerated approval to mobocertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations
FDA
Feb 1, 2022
Replies
0
Views
243
Feb 1, 2022
FDA
F
F
FDA-EMA Parallel Scientific Advice (PSA) Program - 03/16/2022
FDA
Feb 1, 2022
Replies
0
Views
286
Feb 1, 2022
FDA
F
F
Esupplementsales, LLC Issues a Nationwide Recall All Lots of Hard Dawn Due to the Presence of Undeclared Tadalafil
FDA
Feb 1, 2022
Replies
0
Views
240
Feb 1, 2022
FDA
F
F
Activities Report of the Generic Drugs Program (FY 2021) – FDARA Title VIII Section 807 and 805
FDA
Jan 30, 2022
Replies
0
Views
407
Jan 30, 2022
FDA
F
F
Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807 and 805
FDA
Jan 30, 2022
Replies
0
Views
230
Jan 30, 2022
FDA
F
F
Coronavirus Aid, Relief, and Economic Security Act (CARES Act) Drug Shortage Mitigation Efforts
FDA
Jan 30, 2022
Replies
0
Views
288
Jan 30, 2022
FDA
F
F
Guidances (Drugs)
FDA
Jan 30, 2022
Replies
0
Views
323
Jan 30, 2022
FDA
F
F
Laboratory Information Bulletins
FDA
Jan 30, 2022
Replies
0
Views
317
Jan 30, 2022
FDA
F
F
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments
FDA
Jan 29, 2022
Replies
0
Views
284
Jan 29, 2022
FDA
F
F
Postmarket Requirements and Commitments
FDA
Jan 29, 2022
Replies
0
Views
350
Jan 29, 2022
FDA
F
F
AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Polymyxin B for Injection USP, 500,000 Unit per Vial, Due to the Presence of Particulate M
FDA
Jan 29, 2022
Replies
0
Views
260
Jan 29, 2022
FDA
F
Prev
1
…
Go to page
Go
101
102
103
104
105
…
Go to page
Go
126
Next
First
Prev
103 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top